{
  "claim_id": "claim_007",
  "claim": "Recombinant HA antigens produced using BEVS have been shown to induce significantly higher levels of broadly cross-reactive antibodies against highly conserved regions of HA compared with egg-derived vaccines.",
  "document": "Treanor_et_al.__2011_",
  "verification_stats": {
    "total_extracted": 4,
    "verified": 0,
    "rejected": 4,
    "verification_rate": 0.0
  },
  "verified_evidence": [],
  "rejected_evidence": [
    {
      "id": 1,
      "quote": "Comparative immunogen i city of recombinant influenza hemagglutinin (rHA) and trivalent in activated vaccines (TIV) among persons > 65 years old. Vaccine 2009 28 379 85.",
      "reason": "does not support claim",
      "original_explanation": "This reference points to a published study directly comparing the immunogenicity of recombinant HA (produced using BEVS) and egg-derived vaccines, which is relevant to the claim about differences in antibody responses."
    },
    {
      "id": 2,
      "quote": "Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults.",
      "reason": "does not support claim",
      "original_explanation": "This quote supports the claim by stating that recombinant HA vaccines (produced using BEVS) induce protective immune responses, which implies effective antibody induction."
    },
    {
      "id": 3,
      "quote": "Recom- bin ant baculo virus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults.",
      "reason": "does not support claim",
      "original_explanation": "This quote affirms that BEVS-produced recombinant HA vaccines are immunogenic, supporting the claim that they induce strong antibody responses."
    },
    {
      "id": 4,
      "quote": "Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults.",
      "reason": "does not support claim",
      "original_explanation": "This reference describes a study evaluating recombinant HA (insect cell/BEVS) vaccines, which is directly relevant to the claim about their immunogenicity compared to egg-derived vaccines."
    }
  ],
  "model_used": "gpt-4.1"
}